This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: AGU, APH, ANN, ADM

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS



Ariad Pharmaceuticals (ARIA) is upgraded to hold at TheStreet Ratings. Agrium (AGU) estimates and target were reduced at Goldman Sachs. Shares of AGU are now seen reaching $86. Estimates were also cut, given lower realized margins, Goldman said. Neutral rating.

Amphenol (APH) was downgraded at Ticonderoga from Neutral to Sell. Valuation call, based on a $38 price target, Ticonderoga said.

Ann Taylor (ANN) numbers were increased at UBS. Shares are now seen reaching $33. Estimates were also increased on strong sales and margin gains at LOFT, e-commerce and outlets, UBS said. Buy rating.

Archer-Daniels (ADM) was initiated with a Neutral rating at Ticonderoga. The company is trading at book value, but lacks near-term catalysts, Ticonderoga said.

Brocade's (BRCD) target was raised at ThinkEquity. Shares are now seen reaching $6, according to ThinkEquity. Company is carrying a lot of momentum into 2012, ThinkEquity said. Buy rating.

CBOE Holdings (CBOE) estimates were raised at Oppenheimer through 2012. Exceptional market volatility drove an exceptional quarter, Oppenheimer said. Maintain $29 price target and Outperform rating.

Church & Dwight (CHD) numbers were increased at Jefferies. Estimates were raised through 2012. Company is positioned well for a slow-growth environment, Jefferies said. Hold rating and new $43 price target.

Church & Dwight estimates were lowered through 2012 at UBS. Some noise, but a generally in-line quarter, UBS said. Maintain $44 price target and Neutral rating.

Clean Harbors (CLH) numbers were increased at Goldman Sachs. Estimates were raised through 2013. Company is seeing higher sales, Goldman said. Neutral rating and new $57 price target.

CME (CME) target was boosted at Jefferies. Shares are now seen reaching $315. Core business trends are picking up, Jefferies said. Buy rating.

Comcast (CMCSA) estimates, target were cut at Morgan Stanley. Shares are now seen reaching $27. Estimates were also reduced, given lower expected results at NBC Universal, Morgan Stanley said. Equal-weight rating.

Consolidated Edison (ED) numbers were boosted at Goldman Sachs. Shares are now seen reaching $52. Estimates were also increased, given a better outlook for the company's nonregulated assets, Goldman said. Sell rating.

Con-Way (CNW) estimates were lowered at Sterne Agee through 2012. Pension and 401(k) headwinds, Sterne Agee said. Maintain Buy rating and $48 price target.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs